Anticholinergic medication for antipsychotic-induced tardive dyskinesia.
CONCLUSIONS: Based on currently available evidence, no confident statement can be made about the effectiveness of anticholinergics to treat people with antipsychotic-induced tardive dyskinesia. The same applies for the withdrawal of such medications. Whether the withdrawal of anticholinergics may benefit people with antipsychotic-induced TD should be evaluated in a parallel-group, placebo-controlled randomised trial, with adequate sample size and at least 6 weeks of follow-up.
PMID: 29341071 [PubMed - as supplied by publisher]
Source: Cochrane Database of Systematic Reviews - Category: General Medicine Authors: Bergman H, Soares-Weiser K Tags: Cochrane Database Syst Rev Source Type: research
More News: Benztropine | Brain | Clinical Trials | Databases & Libraries | Dyskinesia | General Medicine | Germany Health | Men | Neurology | Schizophrenia | Study